Entering text into the input field will update the search result below

Medtronic Diabetes warning letter removed by FDA

Apr. 25, 2023 4:51 PM ETMedtronic plc (MDT)By: Jonathan Block, SA News Editor3 Comments

Medtronic Corporate Headquarters Campus

Wolterk/iStock Editorial via Getty Images

  • The US FDA has lifted a warning letter issued in December 2021 against Medtronic's (NYSE:MDT) diabetes unit after the company took remediation action.
  • The letter was sent to the unit's Northridge, Calif., headquarters.
  • Medtronic (MDT) added that all regulatory restrictions associated have now been resolved.
  • Just a few days ago, the FDA approved the company's new MiniMed insulin pump.

Recommended For You

Comments (3)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.